Skip to main content
GKSolverGKSolver
HomeExam NewsMCQsMainsUPSC Prep
Login
Menu
Daily
HomeDaily NewsExam NewsStudy Plan
Practice
Essential MCQsEssential MainsUPSC PrepBookmarks
Browse
EditorialsStory ThreadsTrending
Home
Daily
MCQs
Saved
News

© 2025 GKSolver. Free AI-powered UPSC preparation platform.

AboutContactPrivacyTermsDisclaimer
GKSolverGKSolver
HomeExam NewsMCQsMainsUPSC Prep
Login
Menu
Daily
HomeDaily NewsExam NewsStudy Plan
Practice
Essential MCQsEssential MainsUPSC PrepBookmarks
Browse
EditorialsStory ThreadsTrending
Home
Daily
MCQs
Saved
News

© 2025 GKSolver. Free AI-powered UPSC preparation platform.

AboutContactPrivacyTermsDisclaimer
3 minOther

Immunotherapy: Mechanism, Types, and Challenges

A visual representation of the core concepts of immunotherapy, its mechanisms, different types, and the associated challenges, particularly in the Indian context.

This Concept in News

3 news topics

3

Cancer Drug Affordability: Debate Over Keytruda Dosage in India

15 April 2026

Immunotherapy represents a significant advancement in medical science with profound implications for disease treatment and global health equity.

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller Doses

15 April 2026

Immunotherapy represents a paradigm shift in treating complex diseases like cancer, moving from direct assault to empowering the body's own defenses, and its study is critical for understanding modern medical advancements and their societal implications.

IIT-Bombay breakthrough enhances CAR-T cell therapy for cancer

7 February 2026

This news highlights the critical aspect of scalability and accessibility in immunotherapy. CAR-T cell therapy, while promising, has been limited by its complexity and cost. The IIT-Bombay innovation directly addresses this limitation by improving the efficiency of T-cell expansion. This news event demonstrates the practical challenges in translating cutting-edge research into widely available treatments. It applies the concept of immunotherapy by showcasing a specific technological advancement that enhances its effectiveness. The news reveals that overcoming logistical and economic barriers is crucial for the widespread adoption of immunotherapy. The implications of this news are significant, potentially leading to more affordable and accessible cancer treatment options. Understanding immunotherapy is crucial for analyzing this news because it provides the context for appreciating the significance of the IIT-Bombay breakthrough and its potential impact on cancer care.

3 minOther

Immunotherapy: Mechanism, Types, and Challenges

A visual representation of the core concepts of immunotherapy, its mechanisms, different types, and the associated challenges, particularly in the Indian context.

This Concept in News

3 news topics

3

Cancer Drug Affordability: Debate Over Keytruda Dosage in India

15 April 2026

Immunotherapy represents a significant advancement in medical science with profound implications for disease treatment and global health equity.

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller Doses

15 April 2026

Immunotherapy represents a paradigm shift in treating complex diseases like cancer, moving from direct assault to empowering the body's own defenses, and its study is critical for understanding modern medical advancements and their societal implications.

IIT-Bombay breakthrough enhances CAR-T cell therapy for cancer

7 February 2026

This news highlights the critical aspect of scalability and accessibility in immunotherapy. CAR-T cell therapy, while promising, has been limited by its complexity and cost. The IIT-Bombay innovation directly addresses this limitation by improving the efficiency of T-cell expansion. This news event demonstrates the practical challenges in translating cutting-edge research into widely available treatments. It applies the concept of immunotherapy by showcasing a specific technological advancement that enhances its effectiveness. The news reveals that overcoming logistical and economic barriers is crucial for the widespread adoption of immunotherapy. The implications of this news are significant, potentially leading to more affordable and accessible cancer treatment options. Understanding immunotherapy is crucial for analyzing this news because it provides the context for appreciating the significance of the IIT-Bombay breakthrough and its potential impact on cancer care.

Immunotherapy

Harnesses body's immune system

Trains immune cells to fight cancer

Immune Checkpoint Inhibitors (e.g., Keytruda)

Adoptive Cell Transfer (e.g., CAR-T)

Cytokines

High Cost & Access Issues (India)

Dosing Debates (e.g., Keytruda)

Counterfeit Drugs

US FDA Approval Standards

NLEM Inclusion & Price Control

Connections
Core Principle→Key Types
Key Types→Challenges & Debates
Challenges & Debates→Regulatory & Policy Context
Immunotherapy

Harnesses body's immune system

Trains immune cells to fight cancer

Immune Checkpoint Inhibitors (e.g., Keytruda)

Adoptive Cell Transfer (e.g., CAR-T)

Cytokines

High Cost & Access Issues (India)

Dosing Debates (e.g., Keytruda)

Counterfeit Drugs

US FDA Approval Standards

NLEM Inclusion & Price Control

Connections
Core Principle→Key Types
Key Types→Challenges & Debates
Challenges & Debates→Regulatory & Policy Context
  1. Home
  2. /
  3. Concepts
  4. /
  5. Other
  6. /
  7. Immunotherapy
Other

Immunotherapy

What is Immunotherapy?

Immunotherapy is a type of treatment that uses the body's own immune system to fight diseases, including cancer. The immune system is the body's defense against harmful substances like germs and cancer cells. Immunotherapy helps the immune system work harder or smarter to find and attack these harmful substances. It doesn't directly attack the cancer like chemotherapy or radiation. Instead, it boosts the body's natural ability to fight the disease. There are different types of immunotherapy, each working in a unique way to enhance the immune response. The goal of immunotherapy is to achieve long-term control of the disease with fewer side effects than traditional treatments.

Historical Background

The idea of using the immune system to fight cancer dates back to the late 19th century. However, significant progress was made in the 20th century. In 1890s, William Coley, a surgeon, observed that some cancer patients experienced remission after bacterial infections. This led him to develop 'Coley's toxins,' one of the earliest forms of immunotherapy. The discovery of monoclonal antibodies in 1975 by Georges Köhler and César Milstein revolutionized immunotherapy research. In the 1990s, scientists identified immune checkpoints, which are molecules that prevent the immune system from attacking healthy cells. Blocking these checkpoints became a key strategy in immunotherapy. The first immune checkpoint inhibitor, ipilimumab, was approved by the FDA in 2011 for the treatment of melanoma. This marked a turning point in cancer treatment and paved the way for the development of other immunotherapy drugs.

Key Points

12 points
  • 1.

    Immunotherapy uses the body's own immune system to fight cancer and other diseases.

  • 2.

    There are several types of immunotherapy, including checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies, and cancer vaccines.

  • 3.

    Checkpoint inhibitors block proteins that prevent the immune system from attacking cancer cells, allowing the immune system to recognize and destroy them.

  • 4.

    T-cell transfer therapy involves taking immune cells from the patient, modifying them in a lab to better target cancer cells, and then re-infusing them back into the patient.

Visual Insights

Immunotherapy: Mechanism, Types, and Challenges

A visual representation of the core concepts of immunotherapy, its mechanisms, different types, and the associated challenges, particularly in the Indian context.

Immunotherapy

  • ●Core Principle
  • ●Key Types
  • ●Challenges & Debates
  • ●Regulatory & Policy Context

Recent Real-World Examples

3 examples

Illustrated in 3 real-world examples from Feb 2026 to Apr 2026

Apr 2026
2
Feb 2026
1

Cancer Drug Affordability: Debate Over Keytruda Dosage in India

15 Apr 2026

Immunotherapy represents a significant advancement in medical science with profound implications for disease treatment and global health equity.

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller Doses

Related Concepts

Immune Checkpoint InhibitorsPembrolizumabUS FDANational List of Essential MedicinesOncologyPharmaceutical IndustryHealthcare AffordabilityClinical TrialsCAR-T Cell Therapy

Source Topic

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller Doses

Social Issues

UPSC Relevance

Immunotherapy is important for the UPSC exam, particularly for GS-3 (Science and Technology) and GS-2 (Health). It can be asked directly or indirectly. Questions can focus on the types of immunotherapy, their mechanisms, applications, and challenges. In prelims, expect factual questions about specific drugs or techniques. In mains, questions can be analytical, requiring you to discuss the ethical and economic implications of immunotherapy. Recent years have seen an increase in questions related to biotechnology and healthcare innovations. For essay, immunotherapy can be used as an example of scientific advancements improving quality of life. Remember to focus on both the scientific and societal aspects.
❓

Frequently Asked Questions

6
1. What is Immunotherapy and why is it important for the UPSC exam?

Immunotherapy is a type of treatment that uses the body's own immune system to fight diseases, including cancer. It is important for the UPSC exam, particularly for GS-3 (Science and Technology) and GS-2 (Health), as questions can focus on the types of immunotherapy, their mechanisms, applications, and challenges.

Exam Tip

Remember the different types of immunotherapy and their mechanisms of action for the exam.

2. How does Immunotherapy work in practice?

Immunotherapy works by enhancing the body's natural ability to fight diseases. It doesn't directly attack the cancer like chemotherapy or radiation. Instead, it boosts the immune system to find and attack harmful substances like cancer cells. Different types of immunotherapy work in unique ways to enhance the immune response. For example, checkpoint inhibitors block proteins that prevent the immune system from attacking cancer cells.

On This Page

DefinitionHistorical BackgroundKey PointsVisual InsightsReal-World ExamplesRelated ConceptsUPSC RelevanceSource TopicFAQs

Source Topic

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller DosesSocial Issues

Related Concepts

Immune Checkpoint InhibitorsPembrolizumabUS FDANational List of Essential MedicinesOncologyPharmaceutical Industry
  1. Home
  2. /
  3. Concepts
  4. /
  5. Other
  6. /
  7. Immunotherapy
Other

Immunotherapy

What is Immunotherapy?

Immunotherapy is a type of treatment that uses the body's own immune system to fight diseases, including cancer. The immune system is the body's defense against harmful substances like germs and cancer cells. Immunotherapy helps the immune system work harder or smarter to find and attack these harmful substances. It doesn't directly attack the cancer like chemotherapy or radiation. Instead, it boosts the body's natural ability to fight the disease. There are different types of immunotherapy, each working in a unique way to enhance the immune response. The goal of immunotherapy is to achieve long-term control of the disease with fewer side effects than traditional treatments.

Historical Background

The idea of using the immune system to fight cancer dates back to the late 19th century. However, significant progress was made in the 20th century. In 1890s, William Coley, a surgeon, observed that some cancer patients experienced remission after bacterial infections. This led him to develop 'Coley's toxins,' one of the earliest forms of immunotherapy. The discovery of monoclonal antibodies in 1975 by Georges Köhler and César Milstein revolutionized immunotherapy research. In the 1990s, scientists identified immune checkpoints, which are molecules that prevent the immune system from attacking healthy cells. Blocking these checkpoints became a key strategy in immunotherapy. The first immune checkpoint inhibitor, ipilimumab, was approved by the FDA in 2011 for the treatment of melanoma. This marked a turning point in cancer treatment and paved the way for the development of other immunotherapy drugs.

Key Points

12 points
  • 1.

    Immunotherapy uses the body's own immune system to fight cancer and other diseases.

  • 2.

    There are several types of immunotherapy, including checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies, and cancer vaccines.

  • 3.

    Checkpoint inhibitors block proteins that prevent the immune system from attacking cancer cells, allowing the immune system to recognize and destroy them.

  • 4.

    T-cell transfer therapy involves taking immune cells from the patient, modifying them in a lab to better target cancer cells, and then re-infusing them back into the patient.

Visual Insights

Immunotherapy: Mechanism, Types, and Challenges

A visual representation of the core concepts of immunotherapy, its mechanisms, different types, and the associated challenges, particularly in the Indian context.

Immunotherapy

  • ●Core Principle
  • ●Key Types
  • ●Challenges & Debates
  • ●Regulatory & Policy Context

Recent Real-World Examples

3 examples

Illustrated in 3 real-world examples from Feb 2026 to Apr 2026

Apr 2026
2
Feb 2026
1

Cancer Drug Affordability: Debate Over Keytruda Dosage in India

15 Apr 2026

Immunotherapy represents a significant advancement in medical science with profound implications for disease treatment and global health equity.

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller Doses

Related Concepts

Immune Checkpoint InhibitorsPembrolizumabUS FDANational List of Essential MedicinesOncologyPharmaceutical IndustryHealthcare AffordabilityClinical TrialsCAR-T Cell Therapy

Source Topic

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller Doses

Social Issues

UPSC Relevance

Immunotherapy is important for the UPSC exam, particularly for GS-3 (Science and Technology) and GS-2 (Health). It can be asked directly or indirectly. Questions can focus on the types of immunotherapy, their mechanisms, applications, and challenges. In prelims, expect factual questions about specific drugs or techniques. In mains, questions can be analytical, requiring you to discuss the ethical and economic implications of immunotherapy. Recent years have seen an increase in questions related to biotechnology and healthcare innovations. For essay, immunotherapy can be used as an example of scientific advancements improving quality of life. Remember to focus on both the scientific and societal aspects.
❓

Frequently Asked Questions

6
1. What is Immunotherapy and why is it important for the UPSC exam?

Immunotherapy is a type of treatment that uses the body's own immune system to fight diseases, including cancer. It is important for the UPSC exam, particularly for GS-3 (Science and Technology) and GS-2 (Health), as questions can focus on the types of immunotherapy, their mechanisms, applications, and challenges.

Exam Tip

Remember the different types of immunotherapy and their mechanisms of action for the exam.

2. How does Immunotherapy work in practice?

Immunotherapy works by enhancing the body's natural ability to fight diseases. It doesn't directly attack the cancer like chemotherapy or radiation. Instead, it boosts the immune system to find and attack harmful substances like cancer cells. Different types of immunotherapy work in unique ways to enhance the immune response. For example, checkpoint inhibitors block proteins that prevent the immune system from attacking cancer cells.

On This Page

DefinitionHistorical BackgroundKey PointsVisual InsightsReal-World ExamplesRelated ConceptsUPSC RelevanceSource TopicFAQs

Source Topic

Debate on Cancer Drug Affordability: Oncologists Suggest Smaller DosesSocial Issues

Related Concepts

Immune Checkpoint InhibitorsPembrolizumabUS FDANational List of Essential MedicinesOncologyPharmaceutical Industry
5.

Monoclonal antibodies are lab-created antibodies that can target specific proteins on cancer cells, marking them for destruction by the immune system.

  • 6.

    Cancer vaccines stimulate the immune system to recognize and attack cancer cells. Unlike traditional vaccines, they are given after a person has cancer.

  • 7.

    Immunotherapy can be used to treat a variety of cancers, including melanoma, lung cancer, kidney cancer, and lymphoma.

  • 8.

    Side effects of immunotherapy can vary depending on the type of treatment and the individual patient, but can include fatigue, skin rash, and inflammation.

  • 9.

    Immunotherapy is often used in combination with other cancer treatments, such as chemotherapy, radiation therapy, and surgery.

  • 10.

    The effectiveness of immunotherapy can vary depending on the type of cancer, the stage of the disease, and the individual patient's immune system.

  • 11.

    Biomarkers are being developed to help predict which patients are most likely to respond to immunotherapy.

  • 12.

    Research is ongoing to develop new and improved immunotherapy treatments, including personalized therapies tailored to individual patients.

  • 15 Apr 2026

    Immunotherapy represents a paradigm shift in treating complex diseases like cancer, moving from direct assault to empowering the body's own defenses, and its study is critical for understanding modern medical advancements and their societal implications.

    IIT-Bombay breakthrough enhances CAR-T cell therapy for cancer

    7 Feb 2026

    This news highlights the critical aspect of scalability and accessibility in immunotherapy. CAR-T cell therapy, while promising, has been limited by its complexity and cost. The IIT-Bombay innovation directly addresses this limitation by improving the efficiency of T-cell expansion. This news event demonstrates the practical challenges in translating cutting-edge research into widely available treatments. It applies the concept of immunotherapy by showcasing a specific technological advancement that enhances its effectiveness. The news reveals that overcoming logistical and economic barriers is crucial for the widespread adoption of immunotherapy. The implications of this news are significant, potentially leading to more affordable and accessible cancer treatment options. Understanding immunotherapy is crucial for analyzing this news because it provides the context for appreciating the significance of the IIT-Bombay breakthrough and its potential impact on cancer care.

    Bioreactor Technology
    Healthcare Accessibility
    Biotechnology and Pharmaceuticals
    3. What are the different types of Immunotherapy?

    There are several types of immunotherapy, including:

    • •Checkpoint inhibitors
    • •T-cell transfer therapy
    • •Monoclonal antibodies
    • •Cancer vaccines

    Exam Tip

    Make sure to understand the basic principle behind each type of immunotherapy.

    4. What are the key provisions related to Immunotherapy?

    The key provisions related to Immunotherapy are:

    • •Immunotherapy uses the body's own immune system to fight cancer and other diseases.
    • •There are several types of immunotherapy, including checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies, and cancer vaccines.
    • •Checkpoint inhibitors block proteins that prevent the immune system from attacking cancer cells.
    • •T-cell transfer therapy involves modifying immune cells in a lab to better target cancer cells.
    • •Monoclonal antibodies are lab-created antibodies that target specific proteins on cancer cells.

    Exam Tip

    Focus on understanding how each provision contributes to the overall effectiveness of immunotherapy.

    5. What are the challenges in the implementation of Immunotherapy?

    Some challenges in the implementation of immunotherapy include:

    • •High cost of treatment, making it inaccessible for many patients in India.
    • •Limited research and development in India compared to other countries.
    • •Need for specialized infrastructure and trained medical professionals.
    • •Potential side effects and immune-related adverse events.

    Exam Tip

    Consider the socio-economic factors affecting access to advanced treatments like immunotherapy in India.

    6. How has Immunotherapy evolved over time?

    The idea of using the immune system to fight cancer dates back to the late 19th century. Early forms of immunotherapy, like 'Coley's toxins,' were developed in the 1890s. The discovery of monoclonal antibodies in 1975 revolutionized immunotherapy research. Recent developments include initiatives to promote research and development in India and a focus on affordable treatments.

    Exam Tip

    Focus on the timeline of key discoveries and their impact on the development of immunotherapy.

    Healthcare Affordability
    Clinical Trials
    +4 more
    5.

    Monoclonal antibodies are lab-created antibodies that can target specific proteins on cancer cells, marking them for destruction by the immune system.

  • 6.

    Cancer vaccines stimulate the immune system to recognize and attack cancer cells. Unlike traditional vaccines, they are given after a person has cancer.

  • 7.

    Immunotherapy can be used to treat a variety of cancers, including melanoma, lung cancer, kidney cancer, and lymphoma.

  • 8.

    Side effects of immunotherapy can vary depending on the type of treatment and the individual patient, but can include fatigue, skin rash, and inflammation.

  • 9.

    Immunotherapy is often used in combination with other cancer treatments, such as chemotherapy, radiation therapy, and surgery.

  • 10.

    The effectiveness of immunotherapy can vary depending on the type of cancer, the stage of the disease, and the individual patient's immune system.

  • 11.

    Biomarkers are being developed to help predict which patients are most likely to respond to immunotherapy.

  • 12.

    Research is ongoing to develop new and improved immunotherapy treatments, including personalized therapies tailored to individual patients.

  • 15 Apr 2026

    Immunotherapy represents a paradigm shift in treating complex diseases like cancer, moving from direct assault to empowering the body's own defenses, and its study is critical for understanding modern medical advancements and their societal implications.

    IIT-Bombay breakthrough enhances CAR-T cell therapy for cancer

    7 Feb 2026

    This news highlights the critical aspect of scalability and accessibility in immunotherapy. CAR-T cell therapy, while promising, has been limited by its complexity and cost. The IIT-Bombay innovation directly addresses this limitation by improving the efficiency of T-cell expansion. This news event demonstrates the practical challenges in translating cutting-edge research into widely available treatments. It applies the concept of immunotherapy by showcasing a specific technological advancement that enhances its effectiveness. The news reveals that overcoming logistical and economic barriers is crucial for the widespread adoption of immunotherapy. The implications of this news are significant, potentially leading to more affordable and accessible cancer treatment options. Understanding immunotherapy is crucial for analyzing this news because it provides the context for appreciating the significance of the IIT-Bombay breakthrough and its potential impact on cancer care.

    Bioreactor Technology
    Healthcare Accessibility
    Biotechnology and Pharmaceuticals
    3. What are the different types of Immunotherapy?

    There are several types of immunotherapy, including:

    • •Checkpoint inhibitors
    • •T-cell transfer therapy
    • •Monoclonal antibodies
    • •Cancer vaccines

    Exam Tip

    Make sure to understand the basic principle behind each type of immunotherapy.

    4. What are the key provisions related to Immunotherapy?

    The key provisions related to Immunotherapy are:

    • •Immunotherapy uses the body's own immune system to fight cancer and other diseases.
    • •There are several types of immunotherapy, including checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies, and cancer vaccines.
    • •Checkpoint inhibitors block proteins that prevent the immune system from attacking cancer cells.
    • •T-cell transfer therapy involves modifying immune cells in a lab to better target cancer cells.
    • •Monoclonal antibodies are lab-created antibodies that target specific proteins on cancer cells.

    Exam Tip

    Focus on understanding how each provision contributes to the overall effectiveness of immunotherapy.

    5. What are the challenges in the implementation of Immunotherapy?

    Some challenges in the implementation of immunotherapy include:

    • •High cost of treatment, making it inaccessible for many patients in India.
    • •Limited research and development in India compared to other countries.
    • •Need for specialized infrastructure and trained medical professionals.
    • •Potential side effects and immune-related adverse events.

    Exam Tip

    Consider the socio-economic factors affecting access to advanced treatments like immunotherapy in India.

    6. How has Immunotherapy evolved over time?

    The idea of using the immune system to fight cancer dates back to the late 19th century. Early forms of immunotherapy, like 'Coley's toxins,' were developed in the 1890s. The discovery of monoclonal antibodies in 1975 revolutionized immunotherapy research. Recent developments include initiatives to promote research and development in India and a focus on affordable treatments.

    Exam Tip

    Focus on the timeline of key discoveries and their impact on the development of immunotherapy.

    Healthcare Affordability
    Clinical Trials
    +4 more